These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28228373)

  • 1. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review.
    Mozetic V; Freitas CG; Riera R
    JMIR Res Protoc; 2017 Feb; 6(2):e30. PubMed ID: 28228373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis.
    Mozetic V; Pacheco RL; Latorraca COC; Riera R
    Diabetol Metab Syndr; 2019; 11():92. PubMed ID: 31719846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Evans JR
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD006927. PubMed ID: 27490232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioplasty and stenting for below the knee ulcers in diabetic patients: protocol for a systematic review.
    Flumignan CDQ; Amaral FCF; Flumignan RLG; Vasconcelos VT; Attie GA; Daolio RM; Guedes-Neto HJ; de Amorim JE; Baptista-Silva JCC; Nakano LCU
    Syst Rev; 2018 Dec; 7(1):228. PubMed ID: 30537989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2015 Feb; 2(2):CD006927. PubMed ID: 25675254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrates and statins in the treatment of diabetic retinopathy.
    Ansquer JC; Crimet D; Foucher C
    Curr Pharm Biotechnol; 2011 Mar; 12(3):396-405. PubMed ID: 20939802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Brunetti M
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review.
    Shi R; Zhao L; Wang F; Liu F; Chen Z; Li R; Liu Y; Lin R
    Int J Ophthalmol; 2018; 11(2):287-295. PubMed ID: 29487821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of diabetic retinopathy: a systematic review.
    Mohamed Q; Gillies MC; Wong TY
    JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Parravano M; Menchini F; Virgili G
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis.
    Sahebkar A
    Metabolism; 2013 Dec; 62(12):1876-85. PubMed ID: 24095632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Jenkins AJ; Grant MB; Busik JV
    Diabetologia; 2022 Apr; 65(4):587-603. PubMed ID: 35149880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.